Make your money go further for just 25p per day

PREMIUM

Bursting Blue Prism’s bubble: sales growth is not sustainable

Human shaking hands with a robot

Blue Prism is spending too much money on growing sales and not enough on improving products. In 2018 the company invested £65m in staff, travel and entertainment but just £4m in research and development – nowhere near enough to allow it to stand up to rising competition in the long run. With better financed rivals winning new customers at a far quicker pace, we don’t think the group’s pace of growth is sustainable.


The problem with being an early mover in the software market, is that products can quickly look outdated. That is an issue facing Blue Prism (LON: PRSM) which, having been one of the pioneers of the robotics process automation market, is quickly being caught up by newer peers, especially in the US. That might be one of the reasons why the company has announced the £80m acquisition of London-based artificial intelligence company Thoughtonomy. The company…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Blue Prism Group PLC

Look out for the retirement of the baby boomers

23/08/2021 · Your Money

The retirement of the baby boomers is one of the most important economic drivers of this…


A good day for Covid testing companies

17/05/2021 · Company Insights

Inclusion in a framework agreement for NHS England lifted the shares of AIM’s top Covid tester,…


Sign-up to our free email updates

SIGN UP